FDA Enforcement Class II Terminated

V-Series Patient Monitoring System, Manufactured for Mindray DS USA, Inc. Used for monitoring of human physiological parameters. The V-Series Monitor also has the capability of performing IV Drug and Hemodynamic Calculations and interfacing with network devices.

Recall: Z-2059-2014 · Reported July 23, 2014

Enforcement

Recall Number
Z-2059-2014
Event ID
68582
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Mindray DS USA, Inc. dba Mindray North America
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
July 23, 2014
Initiation Date
May 19, 2014
Classification Date
July 16, 2014
Termination Date
April 20, 2017
Address
800 MacArthur Blvd, N/A, Mahwah, NJ, 07430-2001, United States

Description

V-Series Patient Monitoring System, Manufactured for Mindray DS USA, Inc. Used for monitoring of human physiological parameters. The V-Series Monitor also has the capability of performing IV Drug and Hemodynamic Calculations and interfacing with network devices.

Reason

ECG interpretation feature issues. False measurements reported when the algorithm cannot determine P wave or QRS axis. The Median Complex Report displays the representative beat 25% larger than actual signal input. When a patient date of birth is imported from an external source, the ECG interpretation algorithm uses the default age of 50, and interpretive statements may be incorrect.

Code Info

Part Number (P/N): 0998-00-1800-101 and 0998-00-1800-201 with software version 2.4.1.18 in use with 12-lead ECG Module, P/N:0998-00-1804-01 and 0998-00-1804-02.

Distribution

Worldwide Distribution - US including the states of Louisiana, New Jersey, Montana, South Carolina and Wyoming.

Quantity

113 units (57 United States; 56 International)